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FOREWORD 
As in the case of mixed agonist-antagonist narcotic analgesics (see Vol. 
14/Nos. 3,4 of this journal) the Committee on Problems of Drug Depend- 
ence* (CPDD)) organized, as an adjunct to its Annual Scientific Meeting 
in St. Louis, Missouri, June 6-7,1984, a symposium to discuss the scientific 
evidence on the abuse liability of 28 stimulants and hallucinogens under 
consideration by the World Health Organization (WHO) for international 
control. 
Presentations at the symposium were followed by an open discussion 
the tapes of which were edited by Dr. J.H. Woods and Mr. Ed Kaim and 
returned to the participants for comments and final editing, While the tone 
has not been changed markedly by editorial revision there has been a remark- 
able increase in the quality of the discussions. 
In the process of becoming a WHO Collaborating Centre and to meet 
its new responsibilities in this respect, CPDD convened in September 1984 
at the University of Michigan a ‘Consensus Committee’. This ad hoc committee 
had participated in the preceding symposium. They reviewed the scientific 
data available to them on the 28 compounds and with reference to the 
Convention on Psychotropic Substances, 1971 and its Commentary by A. 
Lande* *. The report of the Consensus Committee was reviewed by the 
entire membership of CPDD and submitted to WHO. 
*The CPDD evolved from a committee, founded in 1929, of the National Academy of 
Sciences’ National Research Council. In the mid-1970’s CPDD was incorporated as an 
independent not-for-profit organization. 
CPDD is an international organization of 29 individuals with interest and expertise 
in the chemical (medicinal, synthetic and neurochemical), behavioral, social and clinical 
aspects of substance abuse. Membership consists of two types: the Board of Directors 
and the Executive Committee. The Board of Directors is composed of one representative 
nominated by each of 13 scientific and professional societies whose interests include the 
substance abuse field, but which is not their main focus. The Executive Committee is 
responsible for the direct day to day operation of all activities of CPDD. Its 16 members 
are elected from a slate of individuals with expertise in a variety of disciplines concerned 
with the use of dependence-producing drugs, such as chemistry, pharmacology, medicine, 
psychology and sociology. One member of the Executive Committee must represent the 
public sector (typically a legal expert). 
CPDD has three major functions: sponsorship of an annual scientific meeting; a 
scientific advisory role to academic, governmental, international and industrial agencies 
or institutions regarding drug abuse related issues; and, finally, the development of 
methcds and facilities for the scientific assessment of the abuse liability of pharma- 
ceuticals and other substances so as to provide a base of scientific knowledge for advice 
to the various institutions dealing with these issues. 
**United Nations Publication E/CN.7/589 (1976). 
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The Committee on Problems of Drug Dependence thought it would be 
helpful to all parties concerned, WHO, the United Nations Commission 
on Narcotic Drugs, pharmaceutical companies, and the academic com- 
munity to have an open forum for discussion of the complex issues that 
go into decision-making on the international control of dependence-pro- 
ducing substances. To the extent pertinent information is made more open 
to the scrutiny of all, decisions to control substances with abuse liability 
may be more informed. In this spirit the proceedings of the Symposium 
and the report of the Consensus Committee are reproduced in this special 
issue. 
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